Asphyxia Neonatorum

2

Pipeline Programs↗

0

Active Trials↗

1

Companies Involved↗

Asphyxia Neonatorum is an early-stage landscape with 2 programs across 1 company.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

0/100

Mech. Concentration

100/100

Completion Rate

N/A

Attrition Rate

N/A

Pipeline

Preclinical2

Amikacin

Insmed Incorporated

Magnesium Sulfate

Fresenius Kabi USA, LLC

Phase 1

No programs

Phase 2

No programs

Phase 3

No programs

Approved

No programs

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)